Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...

AstraZeneca ( ($GB:AZN) ) has issued an announcement. AstraZeneca has confirmed that, as of 31 December 2025, its issued share capital with voting ...

AstraZeneca has hailed another phase 3 win for its blood pressure drug candidate baxdrostat, boosting its attempts to turn the molecule’s long half-life into a competitive advantage. Baxdrostat, an ...

AstraZeneca’s ($AZN) breast cancer drug Enhertu has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA).

AstraZeneca said on Monday that a late‑stage trial testing its blockbuster therapy Imfinzi in combination with its ...

For a pharma company selling respiratory drugs, climate change would probably mean more patients and increased sales. But AstraZeneca has committed to contributing its fair share to stop that trend.

As the world went into lockdown a year ago, the workforce of AstraZeneca got news that some at the British-Swedish pharmaceutical giant considered deflating. With a global public health crisis raging ...

European pharma giant AstraZeneca Plc’s (NASDAQ:AZN) Covid vaccine, developed with the University of Oxford, is facing a class action lawsuit alleging its vaccine caused death and serious injury in ...

Katarina Ageborg was appointed head of sustainability at AstraZeneca in 2015 and has served as chief compliance officer since 2011. AstraZeneca recently released its 7th annual sustainability report, ...

AstraZeneca's ambitious $80 billion revenue goal by 2030 hinges on oncology growth and successful new drug launches, but faces patent expiries and fierce competition. While current financials and ...

AstraZeneca has admitted in court for the first time that its Covid jab can cause a deadly blood clotting side effect. The exceedingly rare reaction is at the heart of a multi million-pound class ...

The participant who triggered a global shutdown of AstraZeneca’s Phase 3 Covid-19 vaccine trials was a woman in the United Kingdom who experienced neurological symptoms consistent with a rare but ...